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Gastrointestinal lymphomas accounts for 4-20% of all non-Hodgkin’s lymphomas.
Enteropathy-type T-cell lymphoma (ETTL) accounts for less than 1% of all non-
Hodgkin’s lymphomas.
1,2 There are two types of ETTL according to the Associa-
tion of Celiac Disease. Secondary ETTLs can develop in 7-10% of patients with
gluten-sensitive enteropathy (GSE, celiac disease).
1,3 However, in case of
refractory celiac disease with a phenotypically aberrant intraepithelial T-cell
population, the transition into ETTL is more common (52%).
3 There are also de
novo ETTLs without a preceding history of complicated celiac disease. These
lymphomas also entail a high risk of intestinal perforation or obstruction, and are
refractory to chemotherapy. ETTL generally has a poor prognosis because of its
delayed diagnosis and frequent dissemination.
4 Al-toma, et al.
3 reported a 2-year
survival in the de novo ETTL and secondary ETTL were 20% and 15%, respecti-
vely. We recently encountered a case in which an ETTL caused small bowel
perforation but lacked any association with GSE.
A 73-year-old woman attended our hospital emergency department after a sudden
onset of severe abdominal pain and fever. A physical examination revealed a high
fever (39˚C), a chilling sensation, abdominal tenderness, and muscular defense.
The patient had none of the following symptoms: diarrhea, body-weight loss,
history of malnutrition, or food intolerance. We could not detect any palpable
cervical lymph node.
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Enteropathy-type T-cell lymphoma (ETTL) is a rare disease with a poor prognosis. According to the World Health
Organization (WHO) classification, it is a subtype of the peripheral T-cell lymphomas. This disease is associated
with gluten-sensitive enteropathy, has a high risk of intestinal perforation and obstruction, and is refractory to
chemotherapeutic treatment. We report the case of a 73-year-old woman who was diagnosed with enteropathy-type
T-cell lymphoma of the small intestine, which was positive for the markers of cytotoxic T cells, CD3, CD8, and
CD56, on immunohistochemical staining after resection of the perforated terminal ileum.
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INTRODUCTION
CASE REPORTThe laboratory tests on admission showed mild leuko-
cytosis (white blood cell count of 13,050/mm
2) and azotemia
(serum blood urea nitrogen/creatinine of 18/1.2 mg/dL).
Peripheral blood morphology indicated normocytic
normochromic anemia (hemoglobin of 9.9 g/dL) with
anisopoikilocytosis, and the patterns of serum electro-
phoresis were nonspecific. A chest radiography revealed
no definite free air under the diaphragm. Abdominal
computed tomographic imaging showed an 8.5 cm length
of wall thickening in the distal small bowel, with central
necrosis and pseudoaneurysmal dilatation. Within the
pelvic area, multiple homogeneous enhancing lympha-
denopathies were present on the mesentery near the mass
(Fig. 1). In light of these factors, we planned a laparosco-
pic exploration for a suspected malignant gastrointestinal
stromal tumor (GIST).
The laparoscopic findings showed localized peritonitis
arising from the perforation of the terminal ileum and that
the lesion was adherent to the bladder and the sigmoid
colon. We performed a segmental resection of the perforated
ileum and side-to-side anastomosis through a mini-
laparotomy after a meticulous dissection. The central wall
of the resected ileum was diffusely thickened and it
showed a relatively well-defined encircling the mural mass
measuring 10.0 cm in length. The mass was gray-white to
tan and indicated hemorrhage and necrosis (Fig. 2).
In the pathology report, immunohistochemical staining
was positive for CD5, CD3, CD56, CD8, and Ki-67, and
negative for CD20, CD15, and the Epstein-Barr virus (Fig.
3). The T-cell nature of the tumor was reflected in its reac-
tivity for CD3 and CD8, and its negativity for the B-cell
marker CD20. The patient expressed the HLA-DQ6 and
HLA-DQ9 alleles. On the basis of the immunohistoche-
mical and microscopic findings, we made a diagnosis of
ETTL.
ETTL accounts for less than 1% of all non-Hodgkin’s
lymphomas. It is a subtype of the peripheral T-cell lym-
phomas in the World Health Organization classification
and it is known to develop in 7-10% of patients with long-
standing GSE.
1 A patient with ETTL and GSE generally
presents with diarrhea, food intolerance, and laboratory
findings suggestive of nutrient malabsorption. Immuno-
globulin A antigliadin and antiendomysial antibodies are
also present in the serum. About 90% of patients with GSE
carry the HLA-DQ2 allele.
5 The diagnosis of ETTL re-
quires an adequate biopsy and immunophenotyping.
Macroscopically, ETTL is often multifocal, with ulcerative
lesions mainly on the jejunum, and there is a high risk of
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DISCUSSION
Fig. 1. CT:  wall thickening with central necrosis in small bowel and lympha-
denopathies near the mass.
Fig. 2. A gross pathological specimen: a well-defined encircling mural mass and
perforated ulcers.
Fig. 3. Histopathological findings in the affected terminal ileum. (A) Diffuse
infiltration of atypical lymphocytes with irregularly shaped nuclei (Hematoxylin-
Eosin stain, ×400). (B) Lymphoma cell infiltration by CD3-positive and CD20-
negative T lymphocytes (immunohistochemical stain, ×400).
A
BT-Cell Lymphoma of the Small Bowel
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intestinal perforation and obstruction.
4
Immunophenotyping in most cases demonstrates CD3+,
CD4-, CD8-, and CD1O3+, or occasionally CD3+, CD4-,
CD8+, CD56+, and CD103+, and the cells express mar-
kers of activated cytotoxic T cells.
2 Several studies have
suggested that the Epstein-Barr virus plays an etiological
role in the pathogenesis of ETTL, but this view is still
quite debatable.
6
The treatment of ETTL involves chemotherapy with
clophosphamide, doxorubicin, vincristine, and prednisone
(CHOP).
3 If the ETTL is associated with GSE, gluten
should be withdrawn from the diet.
1,2 However, the disease
is usually highly refractory to chemotherapy and is exacer-
bated by recurrent bowel perforation, obstruction, or other
complications. ETTL is a high-grade intestinal T-cell
lymphoma with a poor prognosis. Novakovic reported that
the one-year and five-year survival rates of patients with
intestinal T-cell non-Hodgkin’s disease are 33% and 9%,
respectively.
2,7
In summary, we report the case of a 73-year-old woman
who was diagnosed with ETTL of the small intestine after
segmental resection of a perforated terminal ileum. 
1. Hönemann D, Prince HM, Hicks RJ, Seymour JF. Enteropathy-
associated T-cell lymphoma without a prior diagnosis of coeliac
disease: diagnostic dilemmas and management options. Ann
Hematol 2005;84:118-21.
2. Ruskoné-Fourmestraux A, Rambaud JC. Gastrointestinal lym-
phoma: prevention and treatment of early lesions. Best Pract Res
Clin Gastroenterol 2001;15:337-54.
3. Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM,
Mulder CJ. Survival in refractory coeliac disease and enteropathy-
associated T-cell lymphoma: retrospective evaluation of single-
centre experience. Gut 2007;56:1373-8.
4. Brousse N, Meijer JW. Malignant complications of coeliac
disease. Best Pract Res Clin Gastroenterol 2005;19:401-12.
5. Ciclitira PJ, Moodie SJ. Transition of care between paediatric and
adult gastroenterology. Coeliac disease. Best Pract Res Clin
Gastroenterol 2003;17:181-95.
6. Kataoka I, Arima F, Nishimoto J, Watanabe T, Kobayashi Y,
Tamura R, et al. Enteropathy-type T-cell lymphoma showing
repeated small bowel rupture and refractoriness to chemotherapy:
a case report. Jpn J Clin Oncol 2002;32:546-9.
7. Novakovic BJ, Novakovic S, Frkovic-Grazio S. A single-center
report on clinical features and treatment response in patients with
intestinal T cell non-Hodgkin’s lymphomas. Oncol Rep 2006;
16:191-5.
REFERENCES